EP1638959 - 5HT -4 -ANTAGONISTIC 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.07.2008 Database last updated on 13.11.2024 | Most recent event Tooltip | 25.07.2008 | No opposition filed within time limit | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
Former [2007/38] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 2340 Beerse / BE | ||
Former [2006/13] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutsebaan 30 2340 Beerse / BE | Inventor(s) | 01 /
BOSMANS, Jean-Paul René Marie André Janssen Pharmaceutica N.V., Turnhoutseweg 30 2340 Beerse / BE | 02 /
GIJSEN, Henricus Jacobus Maria Janssen Pharmaceutica N.V., Turnhoutseweg 30 2340 Beerse / BE | 03 /
MEVELLEC, Laurence Anne, Janssen-Cilag 1, rue Camille Desmoulins TSA 91003 92787 Issy-les-Moulineaux Cedex 9 / FR | [2006/13] | Representative(s) | Verberckmoes, Filip Gerard Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
Former [2006/13] | Verberckmoes, Filip Gerard Janssen Pharmaceutica N.V., J&J Patent Law Department, Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 04736513.5 | 10.06.2004 | [2006/13] | WO2004EP06278 | Priority number, date | WO2003EP50237 | 19.06.2003 Original published format: PCT/EP0350/237 | [2006/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005003122 | Date: | 13.01.2005 | Language: | EN | [2005/02] | Type: | A1 Application with search report | No.: | EP1638959 | Date: | 29.03.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.01.2005 takes the place of the publication of the European patent application. | [2006/13] | Type: | B1 Patent specification | No.: | EP1638959 | Date: | 19.09.2007 | Language: | EN | [2007/38] | Search report(s) | International search report - published on: | EP | 13.01.2005 | Classification | IPC: | C07D405/12, C07D405/14, A61K31/445 | [2006/13] | CPC: |
A61K31/445 (EP,US);
C07D405/12 (EP,KR,US);
A61P1/04 (EP);
A61P1/06 (EP);
A61P1/08 (EP);
A61P1/10 (EP);
A61P1/12 (EP);
A61P1/14 (EP);
A61P13/02 (EP);
A61P13/06 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/14 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/13] | Extension states | AL | 19.01.2006 | HR | 19.01.2006 | LT | 19.01.2006 | LV | 19.01.2006 | MK | 19.01.2006 | Title | German: | 4-(AMINOMETHYL)-PIPERIDINBENZAMIDE ALS 5HT4-ANTAGONISTEN | [2006/13] | English: | 5HT -4 -ANTAGONISTIC 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES | [2006/13] | French: | 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES ANTAGONISTES DES RECEPTEURS 5HT-4 | [2006/13] | Entry into regional phase | 19.01.2006 | National basic fee paid | 19.01.2006 | Designation fee(s) paid | 19.01.2006 | Examination fee paid | Examination procedure | 19.01.2006 | Examination requested [2006/13] | 19.03.2007 | Communication of intention to grant the patent | 30.07.2007 | Fee for grant paid | 30.07.2007 | Fee for publishing/printing paid | Opposition(s) | 20.06.2008 | No opposition filed within time limit [2008/35] | Fees paid | Renewal fee | 30.06.2006 | Renewal fee patent year 03 | 02.07.2007 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0389037 (JANSSEN PHARMACEUTICA NV [BE]) [A] 1 * examples 1-161; table 4 *; | [A]WO9316072 (SMITHKLINE BEECHAM PLC [GB]) [A] 1* claims 1-15 *; | [DX]WO0037461 (JANSSEN PHARMACEUTICA NV [BE], et al) [DX] 1-10 * the whole document * |